User profiles for "author:Beenu Thakral"
Beenu ThakralAssociate Professor, MD Anderson Cancer Center Verified email at mdanderson.org Cited by 2221 |
[HTML][HTML] Systemic mastocytosis and other entities involving mast cells: a practical review and update
S El Hussein, HT Chifotides, JD Khoury, S Verstovsek… - Cancers, 2022 - mdpi.com
Simple Summary In this article, we outline recent updates in systemic mastocytosis (SM)
classification, including the bone marrow mastocytosis subtype; and discuss the mast cell …
classification, including the bone marrow mastocytosis subtype; and discuss the mast cell …
EBV-positive mucocutaneous ulcer in organ transplant recipients: a localized indolent posttransplant lymphoproliferative disorder
M Hart, B Thakral, S Yohe, HH Balfour Jr… - The American journal …, 2014 - journals.lww.com
Abstract Epstein-Barr virus (EBV)-positive mucocutaneous ulcer (EBV MCU) is a B-cell
lymphoproliferative disorder occurring in elderly or iatrogenic immunocompromised patients …
lymphoproliferative disorder occurring in elderly or iatrogenic immunocompromised patients …
Phenotype frequencies of blood group systems (Rh, Kell, Kidd, Duffy, MNS, P, Lewis, and Lutheran) in north Indian blood donors
BACKGROUND: We here report the first study of antigen and phenotype frequencies of
various blood group systems by gel technology in north Indian blood donors. STUDY …
various blood group systems by gel technology in north Indian blood donors. STUDY …
DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high‐risk disease
AE Quesada, MJ Routbort, CD DiNardo… - American journal of …, 2019 - Wiley Online Library
Myeloid neoplasms with germline DDX41 mutations have been incorporated into the 2017
WHO classification. Limited studies describing the clinicopathologic features and mutation …
WHO classification. Limited studies describing the clinicopathologic features and mutation …
A phase 2 study of nivolumab combined with ibrutinib in patients with diffuse large B-cell Richter transformation of CLL
Richter transformation (RT) is a rare complication of chronic lymphocytic leukemia (CLL) that
has dismal outcomes. Upregulation of PD-1/PD-L1 drives immunological evasion in patients …
has dismal outcomes. Upregulation of PD-1/PD-L1 drives immunological evasion in patients …
Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India
Background: Red blood cell (RBC) alloimmunization results from genetic disparity of RBC
antigens between donor and recipients. There is a paucity of data on the incidence of RBC …
antigens between donor and recipients. There is a paucity of data on the incidence of RBC …
Clinicopathologic features and prognostic impact of lymph node involvement in patients with breast implant-associated anaplastic large cell lymphoma
MC Ferrufino-Schmidt, LJ Medeiros, H Liu… - The American journal …, 2018 - journals.lww.com
Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a rare T-cell
lymphoma that arises around breast implants. Most patients manifest with periprosthetic …
lymphoma that arises around breast implants. Most patients manifest with periprosthetic …
Extranodal hematopoietic neoplasms and mimics in the head and neck: an update
B Thakral, J Zhou, LJ Medeiros - Human pathology, 2015 - Elsevier
The head and neck region is a common site for extranodal lymphomas, second only to the
gastrointestinal tract; and 12% to 15% of all head and neck tumors are lymphomas. Non …
gastrointestinal tract; and 12% to 15% of all head and neck tumors are lymphomas. Non …
[HTML][HTML] Nivolumab combined with ibrutinib for CLL and Richter transformation: a phase II trial
Background: Treatment outcomes for patients with CLL have improved with the use of
targeted agents, such as ibrutinib, yet complete remissions (CR) are rare, and the outcomes …
targeted agents, such as ibrutinib, yet complete remissions (CR) are rare, and the outcomes …
Prognostic impact of CD 5 expression in diffuse large B‐cell lymphoma in patients treated with rituximab‐EPOCH
Abstract Objectives CD 5‐positive (CD 5+) diffuse large B‐cell lymphoma (DLBCL)
represents 5%‐10% of all DLBCL cases, which has been associated with a poorer …
represents 5%‐10% of all DLBCL cases, which has been associated with a poorer …